Jack Ferdman1, Fabrice Porcheray, Baoshan Gao, Carolina Moore, Julie DeVito, Sarah Dougherty, Margaret V Thomas, Evan A Farkash, Nahel Elias, Tatsuo Kawai, Sayeed K Malek, Stefan G Tullius, Waichi Wong, Emmanuel Zorn. 1. 1 Transplant Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2 Transplant Center, First Hospital of Jilin University, Changchun, China. 3 Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 4 Division of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 5 Renal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 6 Address correspondence to: Emmanuel Zorn, Ph.D., Massachusetts General Hospital, Transplant Center, Thier 807, 55 Fruit St, Boston, MA 02114.
Abstract
BACKGROUND: B-cell infiltrates are common in rejected kidney allografts, yet their composition is still unclear. The aim of our study was to characterize the clonal composition of B-cell infiltrates of rejected human kidney grafts. METHODS: We used a molecular approach to characterize the partial B-cell repertoires of 5 failed human kidney grafts with detectable B-cell infiltrates. A comparison between the intragraft and blood repertoire was also conducted for 1 case. RESULTS: Redundant sequences were observed in both blood and graft, although the level of clonal amplification was significantly higher for the graft. Somatic hypermutations (SHMs) were also more frequent in sequences found in the graft compared to the blood. The rate of nonsilent mutations was significantly higher in complementarity determining regions (CDRs) compared to framework regions in blood sequences as well as in graft sequences found at low frequency. In contrast, this preferential distribution was lost in sequences found at high frequency in the graft, suggesting a lack of affinity maturation in situ. Lastly, follicular dendritic cells were undetectable in CD20 infiltrates in all samples examined. CONCLUSIONS: We provide here evidence that B-cell clones expand and undergo SHMs in situ. However, the even distribution of nonsilent SHM in high-frequency graft sequences together with the absence of follicular dendritic cells do not support the view that infiltrating B cells are part of functional germinal centers.
BACKGROUND: B-cell infiltrates are common in rejected kidney allografts, yet their composition is still unclear. The aim of our study was to characterize the clonal composition of B-cell infiltrates of rejected human kidney grafts. METHODS: We used a molecular approach to characterize the partial B-cell repertoires of 5 failed human kidney grafts with detectable B-cell infiltrates. A comparison between the intragraft and blood repertoire was also conducted for 1 case. RESULTS: Redundant sequences were observed in both blood and graft, although the level of clonal amplification was significantly higher for the graft. Somatic hypermutations (SHMs) were also more frequent in sequences found in the graft compared to the blood. The rate of nonsilent mutations was significantly higher in complementarity determining regions (CDRs) compared to framework regions in blood sequences as well as in graft sequences found at low frequency. In contrast, this preferential distribution was lost in sequences found at high frequency in the graft, suggesting a lack of affinity maturation in situ. Lastly, follicular dendritic cells were undetectable in CD20 infiltrates in all samples examined. CONCLUSIONS: We provide here evidence that B-cell clones expand and undergo SHMs in situ. However, the even distribution of nonsilent SHM in high-frequency graft sequences together with the absence of follicular dendritic cells do not support the view that infiltrating B cells are part of functional germinal centers.
Authors: Benjamin E Hippen; Angelo DeMattos; William J Cook; Clifton E Kew; Robert S Gaston Journal: Am J Transplant Date: 2005-09 Impact factor: 8.086
Authors: Julong Cheng; Ali Torkamani; Rajesh K Grover; Teresa M Jones; Diana I Ruiz; Nicholas J Schork; Michael M Quigley; F Wesley Hall; Daniel R Salomon; Richard A Lerner Journal: Proc Natl Acad Sci U S A Date: 2011-03-17 Impact factor: 11.205
Authors: F Porcheray; J DeVito; Y Helou; I Dargon; J W Fraser; P Nobecourt; J Ferdman; S Germana; T C Girouard; T Kawai; S L Saidman; W Wong; R B Colvin; C Leguern; E Zorn Journal: Am J Transplant Date: 2012-04-17 Impact factor: 8.086
Authors: Rajesh K Grover; Julong Cheng; Yingjie Peng; Teresa M Jones; Diana I Ruiz; Richard J Ulevitch; John I Glass; Edward A Dennis; Daniel R Salomon; Richard A Lerner Journal: Proc Natl Acad Sci U S A Date: 2012-04-06 Impact factor: 11.205
Authors: Minnie Sarwal; Mei-Sze Chua; Neeraja Kambham; Szu-Chuan Hsieh; Thomas Satterwhite; Marilyn Masek; Oscar Salvatierra Journal: N Engl J Med Date: 2003-07-10 Impact factor: 91.245
Authors: Lufang Liu; Caodi Fang; Whitney Fu; Bo Jiang; Guangxin Li; Lingfeng Qin; Jacob Rosenbluth; Gavin Gong; Catherine B Xie; Peter Yoo; George Tellides; Jordan S Pober; Dan Jane-Wit Journal: Circulation Date: 2019-11-20 Impact factor: 29.690
Authors: S Heidt; M Vergunst; J D H Anholts; G M J S Swings; E M J Gielis; K E Groeneweg; M J Witkamp; J W de Fijter; M E J Reinders; D L Roelen; M Eikmans; F H J Claas Journal: Clin Exp Immunol Date: 2019-02-17 Impact factor: 4.330